Immunitybio Inc.

09/13/2021 | Press release | Distributed by Public on 09/13/2021 06:43

ImmunityBio Announces Positive Durable Responses in BCG Unresponsive Bladder Cancer Patients with a Complete Response Rate of 72%, Median Duration of Complete Response of 19.9[...]